These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17762532)

  • 1. Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden.
    Lincz LF; Adams MJ; Scorgie FE; Thom J; Baker RI; Seldon M
    Blood Coagul Fibrinolysis; 2007 Sep; 18(6):559-64. PubMed ID: 17762532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The -33T-->C polymorphism in intron 7 of the TFPI gene influences the risk of venous thromboembolism, independently of the factor V Leiden and prothrombin mutations.
    Ameziane N; Seguin C; Borgel D; Fumeron F; Moatti D; Alhenc-Gelas M; Grandchamp B; Aiach M; Emmerich J; de Prost D
    Thromb Haemost; 2002 Aug; 88(2):195-9. PubMed ID: 12195688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy.
    Opstad TB; Eilertsen AL; Høibraaten E; Skretting G; Sandset PM
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):516-21. PubMed ID: 20453636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor pathway inhibitor and the risk of recurrent venous thromboembolism.
    Hoke M; Kyrle PA; Minar E; Bialonzcyk C; Hirschl M; Schneider B; Kollars M; Weltermann A; Eichinger S
    Thromb Haemost; 2005 Oct; 94(4):787-90. PubMed ID: 16270631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in the protein C gene as risk factor for venous thrombosis.
    Pomp ER; Doggen CJ; Vos HL; Reitsma PH; Rosendaal FR
    Thromb Haemost; 2009 Jan; 101(1):62-7. PubMed ID: 19132190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of polymorphisms in the human TFPI gene.
    Skretting G; Stavik B; Landvik NE; Myklebust CF; Iversen N; Zienolddiny S; Sandset PM
    Biochem Biophys Res Commun; 2010 Jun; 397(1):106-11. PubMed ID: 20519147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.
    Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M
    Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 536C-->T transition in the human tissue factor pathway inhibitor (TFPI) gene is statistically associated with a higher risk for venous thrombosis.
    Kleesiek K; Schmidt M; Götting C; Schwenz B; Lange S; Müller-Berghaus G; Brinkmann T; Prohaska W
    Thromb Haemost; 1999 Jul; 82(1):1-5. PubMed ID: 10456444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.
    Libourel EJ; Bank I; Meinardi JR; Baljé -Volkers CP; Hamulyak K; Middeldorp S; Koopman MM; van Pampus EC; Prins MH; Büller HR; van der Meer J
    Haematologica; 2002 Oct; 87(10):1068-73. PubMed ID: 12368162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms.
    Bouaziz-Borgi L; Nguyen P; Hezard N; Musharrafieh U; Almawi WY; Mahjoub T
    Exp Mol Pathol; 2007 Dec; 83(3):480-3. PubMed ID: 17555744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation factor V G allele and HR2 haplotype: factor V activity, activated protein C resistance and risk of venous thrombosis.
    Kostka H; Schwarz T; Schellong S; Mix C; Kuhlisch E; Temelkova-Kurktschiev T; Henkel E; Köhler C; Gehrisch S; Siegert G
    Blood Coagul Fibrinolysis; 2003 Jan; 14(1):49-56. PubMed ID: 12544728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tissue factor pathway inhibitor activity in subjects with antiphospholipid syndrome is associated with increased thrombin generation.
    Adams M; Breckler L; Stevens P; Thom J; Baker R; Oostryck R
    Haematologica; 2004 Aug; 89(8):985-90. PubMed ID: 15339683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C536T transition in the tissue factor pathway inhibitor (TFPI) gene does not contribute to risk of venous thrombosis among carriers of factor V Leiden.
    Hessner MJ; Luhm RA
    Thromb Haemost; 2000 Oct; 84(4):724-5. PubMed ID: 11057878
    [No Abstract]   [Full Text] [Related]  

  • 15. [Association of single nucleotide polymorphisms of tissue factor and tissue factor pathway inhibitor with venous thromboembolism in patients with lung cancer].
    Zhang XL; Zhu J; Chen WH; Zhai ZG; Zhang YH
    Zhonghua Yi Xue Za Zhi; 2018 Mar; 98(12):901-906. PubMed ID: 29665662
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of a T-287C polymorphism in the tissue factor pathway inhibitor gene and identification of a repressor element in the promoter.
    Amini Nekoo A; Iles D
    Thromb Res; 2008; 121(6):813-9. PubMed ID: 17931693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism.
    Bergrem A; Dahm AE; Jacobsen AF; Mowinckel MC; Sandvik L; Sandset PM
    Br J Haematol; 2011 Jul; 154(2):241-7. PubMed ID: 21564075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism in the beta2-adrenergic receptor and lipoprotein lipase genes as risk determinants for idiopathic venous thromboembolism: a multilocus, population-based, prospective genetic analysis.
    Zee RY; Cook NR; Cheng S; Erlich HA; Lindpaintner K; Ridker PM
    Circulation; 2006 May; 113(18):2193-200. PubMed ID: 16651467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in exons 6 and 7 of the ABO locus and their association with venous thrombosis in young Brazilian patients.
    Paiva SG; Sabino AP; Carvalho MG; Ribeiro DD; Gomes KB; Santos MS; Oliveira MS; Lages GG; Dusse LM; Fernandes AP
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):122-8. PubMed ID: 19786939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homozygosity in the single nucleotide polymorphism Ser128Arg in the E-selectin gene associated with recurrent venous thromboembolism.
    Jilma B; Kovar FM; Hron G; Endler G; Marsik CL; Eichinger S; Kyrle PA
    Arch Intern Med; 2006 Aug 14-28; 166(15):1655-9. PubMed ID: 16908800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.